Dr Mark Rafferty and Dr Matthew Wilson, consultant haematologists at the Beatson West of Scotland Cancer Centre in Glasgow discuss the role of ctDNA in high grade B-cell lymphoma and its potential function in early detection of relapses with a specific focus on the data presented in Diffuse Large B Cell Lymphoma (DLBCL) space and consider where this technology may fit into UK clinical practice in the future.
Only to be shared with relevant UK haematology healthcare professionals.
CPD® Accreditation
To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.
Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.
